Experienced in Generalized Resistance to Thyroid Hormone

Ariel Tenenbaum

Hadassah Medical Center Mt. Scopus
Jerusalem, JM, IL 
Experienced in Generalized Resistance to Thyroid Hormone
Hadassah Medical Center Mt. Scopus
Jerusalem, JM, IL 
OverviewLocationsClinical Research

Overview

Ariel Tenenbaum practices in Jerusalem, Israel. Tenenbaum is rated as an Experienced expert by MediFind in the treatment of Generalized Resistance to Thyroid Hormone. Their top areas of expertise are Down Syndrome, Chemical Pneumonitis, Type 1 Diabetes (T1D), and Diabetic Ketoacidosis.

Their clinical research consists of co-authoring 70 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Hadassah Medical Center Mt. Scopus
Jerusalem, JM, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Double Blind, Randomized , Placebo Controlled Study to Evaluate the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Girls
Double Blind, Randomized , Placebo Controlled Study to Evaluate the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Girls
Enrollment Status: Completed
Publish Date: May 16, 2025
Intervention Type: Dietary supplement
Study Phase: Not Applicable
Patients Perceptions of Using the Libre System Compared With Conventional SMBG in Adolescents With Type 1 Diabetes The Libre Sat Trial
Patients Perceptions of Using the Libre System Compared With Conventional SMBG in Adolescents With Type 1 Diabetes The Libre Sat Trial
Enrollment Status: Completed
Publish Date: August 09, 2022
Intervention Type: Device
Study Phase: Not Applicable
Determination of Automated Multiple Insulin Dose Injections Settings Using the MDI/SMBG Advisor for Patients With Type 1 Diabetes -Data Collection, Observational & Proof of Concept Study
Determination of Automated Multiple Insulin Dose Injections Settings Using the MDI/SMBG Advisor for Patients With Type 1 Diabetes -Data Collection, Observational & Proof of Concept Study
Enrollment Status: Terminated
Publish Date: December 01, 2020
Intervention Type: Device
Study Phase: Not Applicable
An Open-label, Two-center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 Diabetes at Home
An Open-label, Two-center, Randomized, Cross-over Study to Evaluate the Safety and Efficacy of Night Closed-loop Control Using the MD-Logic Automated Insulin Delivery System Compared to Sensor Augmented Pump Therapy in Poorly Controlled Patients With Type 1 Diabetes at Home
Enrollment Status: Withdrawn
Publish Date: December 30, 2019
Intervention Type: Device
Study Phase: Not Applicable
Comparison of Two Closed-Loop Strategies for Glucose Control in Type 1 Diabetes The DREMED Trail- 2
Comparison of Two Closed-Loop Strategies for Glucose Control in Type 1 Diabetes The DREMED Trail- 2
Enrollment Status: Completed
Publish Date: December 27, 2019
Intervention Type: Device
Study Phase: Not Applicable
The Cost-efficacy of Psychological Intervention for Strengthening Parental Authority Among Parents of Diabetic Adolescents With Poor Glycemic Control
The Cost-efficacy of Psychological Intervention for Strengthening Parental Authority Among Parents of Diabetic Adolescents With Poor Glycemic Control
Enrollment Status: Completed
Publish Date: May 15, 2018
Intervention Type: Behavioral
Study Phase: Not Applicable
The Influence of Growth Hormone (GH) Therapy on Short Stature Related Distress a Prospective Randomized Controlled Trial
The Influence of Growth Hormone (GH) Therapy on Short Stature Related Distress a Prospective Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: December 20, 2017
Intervention Type: Drug
Study Phase: Phase 4
Evaluation of Automated-Insulin Pump Setting Using the MD-Logic Pump Advisor -Minors Sub Study
Evaluation of Automated-Insulin Pump Setting Using the MD-Logic Pump Advisor -Minors Sub Study
Enrollment Status: Completed
Publish Date: January 11, 2017
Intervention Type: Device
Study Phase: Not Applicable
View 7 Less Clinical Trials

70 Total Publications

Central precocious puberty in males, GnRHa-treated or untreated, did not impact fertility and health in mid-adulthood.
Central precocious puberty in males, GnRHa-treated or untreated, did not impact fertility and health in mid-adulthood.
Journal: The Journal of clinical endocrinology and metabolism
Published: May 18, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Tenenbaum's expertise for a condition
ConditionClose
      View All 32 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile